A patient has requested her prescription early. I have never met her, but I can see in her notes that six weeks ago she got them early because she said she had lost all her pills in a waterfall
In sometimes impassioned testimony, Cynthia Sharpe described how more detailed information on an epilepsy drug swap painted a much more dangerous picture of the risks for patients
You can’t benchmark our medicines funding against other countries’ without also scrutinising Pharmac’s fixed budget, argues Cancer Society medical director Chris Jackson
A patient has requested her prescription early. I have never met her, but I can see in her notes that six weeks ago she got them early because she said she had lost all her pills in a waterfall
Your patient uses gliclazide and insulin but could still benefit from the additional cardiovascular and renal protections of empagliflozin. How would you manage the change in treatment?
Consultant cardiologist Chris Ellis discusses how to address a patient’s concerns about statin side effects, and the evidence and strategies useful to reassure them
Medicines New Zealand, the industry association representing companies involved in the research, development and manufacture of modern medicines and vaccines, is supportive of the proposed review into PHARMAC if it is intended to improve the existing system and enhance modern medicines access for patients and the health system
The chair of Pharmac’s Pharmacology and Therapeutics Advisory Committee was grilled today over the body’s approach to assessing whether a controversial drug-funding switch should have taken place
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management